Kroeger Christopher A. bought MPLT
October 28, 2025 · Form 4 insider transaction
Kroeger Christopher A. bought 3,895 shares of MapLight Therapeutics, Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,895
Price
N/A
Total value
N/A
InsiderKroeger Christopher A.
RoleOfficer, Director
SecurityVoting Common Stock
Transaction codeC: Conversion of a derivative
Transaction dateOctober 28, 2025
Filing dateOctober 28, 2025
Shares owned after229,588
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Series C Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's IPO for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.